Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biotech-IgG Securities (publ) AB
AB
Bankrupt
Org 5590179437
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 11 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biotech-IgG Securities (publ) AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
Income statement
SEK thousands
Item
2022
2021
2020
2019
2018
Revenue
0
0
1
0
0
Staff expenses
—
—
—
—
—
EBITDA
−204
−125
−96
−115
−151
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−204
−125
−96
−115
−151
Net financials
—
−238
−632
−765
−89 919
Profit before tax
−204
−363
−728
−574
−90 070
Tax
−0
−0
−0
−0
−0
Net profit
−204
−363
−728
−574
−90 070
Balance sheet
SEK thousands
Item
2022
2021
2020
2019
2018
Total assets
10 661
10 350
10 815
11 445
477
Equity
506
310
223
951
326
Long-term debt
0
0
0
0
0
Short-term debt
10 155
10 040
10 592
10 493
151
Total debt
10 155
10 040
10 592
10 493
151
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2018
2022
Equity ratio
4,7 %
This company
38,2 %
Market median
This company
Market median
88% below market
2018
2022
Return on equity
−40,3 %
This company
18,4 %
Market median
This company
Market median
319% below market
2018
2022
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2018
2022
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2018
2022
Debt / equity
20,07×
This company
0,62×
Market median
This company
Market median
>999% above market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
More on Biotech-IgG Securities (publ) AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
